Review of ACR hematologic criteria in systemic lupus erythematosus

Lupus

Volumn 13, Issue 11, 2004, Pages 865-868

  Kao, A H ^a   Manzi, S ^a,b   Ramsey Goldman, R ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ACR criteria; Anemia; Hematology; Leukopenia; Lymphopenia; SLICC; Systemic lupus; Thrombocytopenia

Indexed keywords

CORTICOSTEROID DERIVATIVE; CYTOTOXIC AGENT;

CLINICAL FEATURE; CYTOPENIA; DIAGNOSTIC ACCURACY; HEMATOLOGIC DISEASE; HEMATOLOGY; HEMOLYTIC ANEMIA; HUMAN; LEUKOPENIA; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MEDICAL SCHOOL; PREVALENCE; PRIORITY JOURNAL; RETICULOCYTOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VIRUS INFECTION;

ANEMIA, HEMOLYTIC; HEMATOLOGIC DISEASES; HUMANS; LEUKOPENIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOPENIA; THROMBOCYTOPENIA;

EID: 9244230658     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu2025oa     Document Type: Review

References (28)

1. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
2. Jacobsen S, Petersen J, Ullman S et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998; 17: 468-477.
3. Cooper GS, Parks CG, Treadwell EL et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 2002; 11: 161-167.
4. Iqbal S, Sher MR, Good RA, Cawkwell GD. Diversity in presenting manifestations of systemic lupus erythematosus in children. J Pediatr 1999; 135: 500-505.
5. Mirzayan MJ, Schmidt RE, Witte T. Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology (Oxford) 2000; 39: 1316-1319.
6. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996; 156: 1337-1344.
7. Kokori SI, Ioannidis JP, Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med 2000; 108: 198-204.
8. Nossent JC, Swaak AJ. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med 1991; 80: 605-612.
9. Deleze M, Alarcon-Segovia D, Oria CV et al. Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1989; 16: 926-930.
10. Sultan SM, Begum S, Isenberg DA. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. Rheumatology (Oxford) 2003; 42: 230-234.
11. Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 1964; 190: 104-111.
12. Rivero SJ, Diaz-Jouanen E, Alarcon-Segovia D. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum 1978; 21: 295-305.
13. Bloemena E, Weinreich S, Schellekens PT. The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo. Clin Exp Immunol 1990; 80: 460-466.
14. Georgescu L, Vakkalanka RK, Elkon KB, Crow MK. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest 1997; 100: 2622-2633.
15. Winfield JB. Anti-lymphocyte antibodies in systemic lupus erythematosus. Clin Rheum Dis 1985; 11: 523-549.
16. Castelino DJ, McNair P, Kay TW. Lymphocytopenia in a hospital population - what does it signify? Aust NZ J Med 1997; 27: 170-174.
17. Wenzel J, Bauer R, Uerlich M, Bieber T, Boehm I. The value of lymphocytopenia as a marker of systemic involvement in cutaneous lupus erythematosus. Br J Dermatol 2002; 146: 869-871.
18. Silva LM, Garcia AB, Donadi EA. Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations. J Neurol 2002; 249: 1048-1054.
19. Rabinowitz Y, Dameshek W. Systemic lupus erytematosus after 'idiopathic' thrombocytopenic purpura: a review. Ann Intern Med 1960; 52: 1-28.
20. Pamuk GE, Pamuk ON, Baslar Z et al. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Ann Hematol 2002; 81: 436-440.
21. Mestanza-Peralta M, Ariza-Ariza R, Cardiel MH, Alcocer-Varela J. Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus. J Rheumatol 1997; 24: 867-870.
22. Feinglass EJ, Arnett FC, Dorsch CA, Zizic TM, Stevens MB. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine 1976; 55: 323-339.
23. Alger M, Alarcon-Segovia D, Rivero SJ. Hemolytic anemia and thrombocytopenic purpura: two related subsets of systemic lupus erythematosus. J Rheumatol 1977; 4: 351-357.
24. Miller MH, Urowitz MB, Gladman DD. The significance of thrombocytopenia in systemic lupus erythematosus. Arthritis Rheum 1983; 26: 1181-1186.
25. Mok CC, Lee KW, Ho CT, Lau CS, Wong RW. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford) 2000; 39: 399-406.
26. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990; 33: 37-48.
27. Massardo L, Martinez ME, Jacobelli S, Villarroel L, Rosenberg H, Rivero S. Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum 1994; 24: 1-11.
28. Scofield RH, Bruner GR, Kelly JA et al. Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13. Blood 2003; 101: 992-997.